Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Hwang

Showing results (301-310 of 346) with videos related to

Pageof 35
Sort By:
AJNR. American Journal of Neuroradiology|December 7, 2019
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic ValueI Hwang, S H Choi, C-K Park, et al.
Oncogene|October 10, 2012
Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastomaB A Emmenegger, E I Hwang, C Moore, et al.
BJU International|November 17, 2009
Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean menSang E Lee, Dae S Kim, Won K Lee, et al.
Journal of Translational Medicine|September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralizationAllison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
Psychological Medicine|April 5, 2017
Using self-report surveys at the beginning of service to develop multi-outcome risk models for new soldiers in the U.S. ArmyA J Rosellini, M B Stein, D M Benedek, et al.
Immunology Letters|September 21, 2000
CM1, a possible novel activation molecule on human lymphocytesD Y Hur, S Kim, Y I Kim, et al.
Blood|May 19, 2012
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4Qian Liu, Haoqian Chen, Teresa Ojode, et al.
Journal of Neuro-Oncology|April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)Mariko DeWire, Maryam Fouladi, David C Turner, et al.
Liver Cancer|November 30, 2018
Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma TreatmentPi-Yi Chang, Chun-Chieh Huang, Chao-Hung Hung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Pageof 35

Showing results (301-310 of 346) with videos related to

Sort By:
Pageof 35
AJNR. American Journal of Neuroradiology|December 7, 2019
Dynamic Contrast-Enhanced MR Imaging of Nonenhancing T2 High-Signal-Intensity Lesions in Baseline and Posttreatment Glioblastoma: Temporal Change and Prognostic ValueI Hwang, S H Choi, C-K Park, et al.
Oncogene|October 10, 2012
Distinct roles for fibroblast growth factor signaling in cerebellar development and medulloblastomaB A Emmenegger, E I Hwang, C Moore, et al.
BJU International|November 17, 2009
Application of the Epstein criteria for prediction of clinically insignificant prostate cancer in Korean menSang E Lee, Dae S Kim, Won K Lee, et al.
Journal of Translational Medicine|September 25, 2019
Medulloblastoma rendered susceptible to NK-cell attack by TGFβ neutralizationAllison B Powell, Sridevi Yadavilli, Devin Saunders, et al.
Psychological Medicine|April 5, 2017
Using self-report surveys at the beginning of service to develop multi-outcome risk models for new soldiers in the U.S. ArmyA J Rosellini, M B Stein, D M Benedek, et al.
Immunology Letters|September 21, 2000
CM1, a possible novel activation molecule on human lymphocytesD Y Hur, S Kim, Y I Kim, et al.
Blood|May 19, 2012
WHIM syndrome caused by a single amino acid substitution in the carboxy-tail of chemokine receptor CXCR4Qian Liu, Haoqian Chen, Teresa Ojode, et al.
Journal of Neuro-Oncology|April 11, 2015
An open-label, two-stage, phase II study of bevacizumab and lapatinib in children with recurrent or refractory ependymoma: a collaborative ependymoma research network study (CERN)Mariko DeWire, Maryam Fouladi, David C Turner, et al.
Liver Cancer|November 30, 2018
Multidisciplinary Taiwan Consensus Recommendations for the Use of DEBDOX-TACE in Hepatocellular Carcinoma TreatmentPi-Yi Chang, Chun-Chieh Huang, Chao-Hung Hung, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 6, 2021
A Phase I and Surgical Study of Ribociclib and Everolimus in Children with Recurrent or Refractory Malignant Brain Tumors: A Pediatric Brain Tumor Consortium StudyMariko D DeWire, Christine Fuller, Olivia Campagne, et al.
Pageof 35